Stockreport

Alvotech higher on positive data backing biosimilar to Takeda's Entyvio [Seeking Alpha]

Alvotech - Ordinary Shares  (ALVO) 
PDF to evaluate AVT80, its proposed biosimilar to Entyvio, a bowel disease therapy marketed by Takeda ( TAK Citing topline data, Alvotech ( Recommended For You More Tr [Read more]